American Banking and Market News logo

The Latest Headlines at American Banking and Market News

Image about Lululemon Athletica (NASDAQ:LULU) Coverage Initiated at BTIG Research

Lululemon Athletica (NASDAQ:LULU) Coverage Initiated at BTIG Research

BTIG Research started coverage on shares of Lululemon Athletica (NASDAQ:LULU – Free Report) in a research report report published on Wednesday morning, StockNewsAPI reports. The brokerage issued a buy rating and a $425.00 target... More of this article »
Image about Myriad Genetics (NASDAQ:MYGN) Upgraded to Outperform at SVB Leerink

Myriad Genetics (NASDAQ:MYGN) Upgraded to Outperform at SVB Leerink

SVB Leerink upgraded shares of Myriad Genetics (NASDAQ:MYGN – Free Report) from a market perform rating to an outperform rating in a report published on Wednesday, MarketBeat.com reports. SVB Leerink currently has $35.00 price... More of this article »
Image about Chart Industries (NYSE:GTLS) Now Covered by Analysts at Barclays

Chart Industries (NYSE:GTLS) Now Covered by Analysts at Barclays

Barclays initiated coverage on shares of Chart Industries (NYSE:GTLS – Free Report) in a report issued on Wednesday, Marketbeat reports. The brokerage issued an equal weight rating and a $193.00 price target on the industrial... More of this article »
Image about Mizuho Cuts uniQure (NASDAQ:QURE) Price Target to $6.00

Mizuho Cuts uniQure (NASDAQ:QURE) Price Target to $6.00

uniQure (NASDAQ:QURE – Free Report) had its target price reduced by Mizuho from $7.00 to $6.00 in a report released on Wednesday, Benzinga reports. Mizuho currently has a neutral rating on the biotechnology company’s stock. A... More of this article »
Image about Mizuho Trims Shoals Technologies Group (NASDAQ:SHLS) Target Price to $13.00

Mizuho Trims Shoals Technologies Group (NASDAQ:SHLS) Target Price to $13.00

Shoals Technologies Group (NASDAQ:SHLS – Free Report) had its price target lowered by Mizuho from $16.00 to $13.00 in a report published on Wednesday, Benzinga reports. The firm currently has a buy rating on the stock. Other... More of this article »
Image about Heron Therapeutics’ (HRTX) Buy Rating Reaffirmed at Needham & Company LLC

Heron Therapeutics’ (HRTX) Buy Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC restated their buy rating on shares of Heron Therapeutics (NASDAQ:HRTX – Free Report) in a research report released on Wednesday, Benzinga reports. They currently have a $5.00 price target on the biotechnology... More of this article »
Image about Inogen (NASDAQ:INGN) Stock Rating Reaffirmed by Needham & Company LLC

Inogen (NASDAQ:INGN) Stock Rating Reaffirmed by Needham & Company LLC

Needham & Company LLC reiterated their hold rating on shares of Inogen (NASDAQ:INGN – Free Report) in a report issued on Wednesday, Benzinga reports. Separately, William Blair raised shares of Inogen from a market perform... More of this article »
Image about MoneyLion (NYSE:ML) Given New $100.00 Price Target at Needham & Company LLC

MoneyLion (NYSE:ML) Given New $100.00 Price Target at Needham & Company LLC

MoneyLion (NYSE:ML – Free Report) had its target price upped by Needham & Company LLC from $90.00 to $100.00 in a report issued on Wednesday morning, Benzinga reports. They currently have a buy rating on the stock. ML has... More of this article »
Image about Solid Power’s (SLDP) Buy Rating Reaffirmed at Needham & Company LLC

Solid Power’s (SLDP) Buy Rating Reaffirmed at Needham & Company LLC

Needham & Company LLC restated their buy rating on shares of Solid Power (NASDAQ:SLDP – Free Report) in a report issued on Wednesday, Benzinga reports. They currently have a $3.00 price target on the stock. SLDP has been... More of this article »
Image about Cogent Biosciences (NASDAQ:COGT) Stock Rating Reaffirmed by Needham & Company LLC

Cogent Biosciences (NASDAQ:COGT) Stock Rating Reaffirmed by Needham & Company LLC

Needham & Company LLC reissued their buy rating on shares of Cogent Biosciences (NASDAQ:COGT – Free Report) in a report released on Wednesday morning, Benzinga reports. They currently have a $18.00 price objective on the... More of this article »
Image about Needham & Company LLC Reiterates “Buy” Rating for Immuneering (NASDAQ:IMRX)

Needham & Company LLC Reiterates “Buy” Rating for Immuneering (NASDAQ:IMRX)

Needham & Company LLC reiterated their buy rating on shares of Immuneering (NASDAQ:IMRX – Free Report) in a research report released on Wednesday morning, Benzinga reports. The brokerage currently has a $15.00 price objective... More of this article »
Image about Advanced Micro Devices (NASDAQ:AMD) Stock Price Down 0.5%

Advanced Micro Devices (NASDAQ:AMD) Stock Price Down 0.5%

Advanced Micro Devices, Inc. (NASDAQ:AMD – Get Free Report) traded down 0.5% on Friday . The stock traded as low as $151.43 and last traded at $151.60. 19,628,389 shares changed hands during trading, a decline of 72% from the... More of this article »
Image about Curis’ (CRIS) “Buy” Rating Reaffirmed at HC Wainwright

Curis’ (CRIS) “Buy” Rating Reaffirmed at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Curis (NASDAQ:CRIS – Free Report) in a report released on Wednesday, Benzinga reports. HC Wainwright currently has a $26.00 target price on the biotechnology company’s... More of this article »
Image about Pfizer (NYSE:PFE) Stock Price Down 0.5%

Pfizer (NYSE:PFE) Stock Price Down 0.5%

Pfizer Inc. (NYSE:PFE – Get Free Report) traded down 0.5% during trading on Friday . The company traded as low as $27.99 and last traded at $28.04. 7,027,748 shares changed hands during mid-day trading, a decline of 84% from... More of this article »
Image about Ligand Pharmaceuticals (NASDAQ:LGND) Rating Reiterated by HC Wainwright

Ligand Pharmaceuticals (NASDAQ:LGND) Rating Reiterated by HC Wainwright

HC Wainwright reiterated their buy rating on shares of Ligand Pharmaceuticals (NASDAQ:LGND – Free Report) in a research report released on Wednesday morning, Benzinga reports. They currently have a $144.00 price target on the... More of this article »